Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kahal

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 3, 2019
The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controlsH Kahal, Es Kilpatrick, As Rigby, et al.
Clinical Endocrinology|November 22, 2013
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver diseaseH Kahal, G Abouda, A S Rigby, et al.
Diabetes & Metabolism|May 23, 2018
Platelet function following induced hypoglycaemia in type 2 diabetesH Kahal, A Aburima, B Spurgeon, et al.
Clinical Endocrinology|January 3, 2013
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesityH Kahal, A Aburima, T Ungvari, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|January 3, 2019
The effects of treatment with liraglutide on quality of life and depression in young obese women with PCOS and controlsH Kahal, Es Kilpatrick, As Rigby, et al.
Clinical Endocrinology|November 22, 2013
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver diseaseH Kahal, G Abouda, A S Rigby, et al.
Diabetes & Metabolism|May 23, 2018
Platelet function following induced hypoglycaemia in type 2 diabetesH Kahal, A Aburima, B Spurgeon, et al.
Clinical Endocrinology|January 3, 2013
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesityH Kahal, A Aburima, T Ungvari, et al.
Pageof 1